Hemopexin ELISA试剂盒

Marfà, Morales-Ruiz, Oró, Ribera, Fernández-Varo, Jiménez: "Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats." in: Biology open, Vol. 5, Issue 6, pp. 858-65, (2016) (PubMed).

Aung, Dixon, Smith, Sweeney, Robson, Berney, Buxton, Green, Cook: "Novel regulatory roles of cAMP receptor proteins in fast-growing environmental mycobacteria." in: Microbiology (Reading, England), Vol. 161, Issue Pt 3, pp. 648-61, (2015) (PubMed).

Prentice, Zhao, Johnson, Aragaki, Hsia, Jackson, Rossouw, Manson, Hanash: "Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases." in: Genome medicine, Vol. 5, Issue 12, pp. 112, (2014) (PubMed).

Pohl, Danz, Gross, John, Urban, Patzer, Habbig, Feldkötter, Witzke, Walther, Rhode: "Diagnosis of Alport syndrome-search for proteomic biomarkers in body fluids." in: Pediatric nephrology (Berlin, Germany), (2013) (PubMed).

Kobayashi, Nouso, Kinugasa, Takeuchi, Tomoda, Miyahara, Hagihara, Kuwaki, Onishi, Nakamura, Ikeda, Miyake, Shiraha, Takaki, Yamamoto: "Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma." in: Hepatology research : the official journal of the Japan Society of Hepatology, (2012) (PubMed).

Suzuki, Namiki: "[Serum hemopexin: suppressive effect on neutrophil functions and prospect of clinical application to autoimmune diseases]." in: Nihon rinsho. Japanese journal of clinical medicine, Vol. 62, Issue 3, pp. 577-86, (2004) (PubMed).

Yu, Chertkow, Bergman, Schipper: "Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma." in: Proteomics, Vol. 3, Issue 11, pp. 2240-8, (2003) (PubMed).